/Merck%20%26%20Co%20Inc%20HQ%20-by%20Sundry%20Photography%20via%20iStock.jpg)
The fifth-largest healthcare stock in the S&P 500 Index ($SPX) is proving that just because a stock is down 30%, it’s not a screaming buy.
It is all right there for value investors, isn’t it? Merck is a blue-chip stock, a Dow Jones Industrial Average ($DOWI) component, and it sells at 11.5x trailing earnings. It even pays a robust 3.6% dividend yield. What’s not to like?